Daniel S. Lorrain sold $595K of Contineum Therapeutics, Inc. (CTNM) stock

Daniel S. Lorrain, Chief Scientific Officer of Contineum Therapeutics, Inc. (CTNM), sold 37,179 shares of CTNM stock worth $595K, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 30, 2026, 2 days before it was made public.

CTNM has moved -18.2% since the trade date, from $16.39 to $13.40 (Sep 22, 2026 close).